Which pharmacokinetic property is true of enalapril?

The pharmacokinetic property that is true of enalapril is that peak concentration is seen 4-8 hours after administration. This timing reflects the absorption and distribution characteristics of enalapril, which is an ACE inhibitor used primarily for the treatment of hypertension and heart failure. Following oral administration, enalapril is metabolized to its active form, enalaprilat, and the peak plasma levels occur within this timeframe as the drug reaches steady-state concentrations in the bloodstream.

Understanding the pharmacokinetics of enalapril is crucial for optimizing its clinical use, particularly in determining the appropriate timing for dosage adjustments and monitoring therapeutic effects. The recognition of when peak concentration occurs can guide healthcare professionals in assessing efficacy and potential side effects.